84 related articles for article (PubMed ID: 2122247)
1. In vitro and in vivo activity of antifungal agents in combination with fleroxacin, a new quinolone.
Polak A
Mycoses; 1990 Apr; 33(4):173-8. PubMed ID: 2122247
[TBL] [Abstract][Full Text] [Related]
2. In Vitro and in Vivo Activity of Antifungal Agents in Combination with Fleroxacin, a New Quinolone.
Polak A
Mycoses; 1990 Apr; 33(4):172-178. PubMed ID: 29265569
[TBL] [Abstract][Full Text] [Related]
3. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of antifungal agents in combination with four quinolones.
Petrou MA; Rogers TR
Drugs Exp Clin Res; 1988; 14(1):9-18. PubMed ID: 3292181
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo studies on synergistic antifungal activity.
Shadomy S
Contrib Microbiol Immunol; 1977; 4():147-57. PubMed ID: 342191
[No Abstract] [Full Text] [Related]
6. In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera.
Vitale RG; Afeltra J; de Hoog GS; Rijs AJ; Verweij PE
J Antimicrob Chemother; 2003 May; 51(5):1297-300. PubMed ID: 12697648
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Polak A
Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362
[TBL] [Abstract][Full Text] [Related]
8. Azole resistance in Candida albicans.
Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
[TBL] [Abstract][Full Text] [Related]
9. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.
An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y
Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412
[TBL] [Abstract][Full Text] [Related]
10. [The activity of systemic antimycotic drug combinations].
Viudes A; Pemán J; Cantón E; López-Ribot J; Gobernado M
Rev Esp Quimioter; 2001 Mar; 14(1):30-9. PubMed ID: 11376347
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
Kutsyk RV; Pavliuk TD
Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
Strippoli V; Torosantucci A; Simonetti N
Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs.
Sugar AM; Liu XP; Chen RJ
Antimicrob Agents Chemother; 1997 Nov; 41(11):2518-21. PubMed ID: 9371359
[TBL] [Abstract][Full Text] [Related]
16. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of commonly used antifungal agents in the presence of rifampin, polymyxin B and norfloxacin against Candida albicans.
Moneib NA
J Chemother; 1995 Dec; 7(6):525-9. PubMed ID: 8667037
[TBL] [Abstract][Full Text] [Related]
18. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds.
Wakabayashi H; Okutomi T; Abe S; Hayasawa H; Tomita M; Yamaguchi H
Adv Exp Med Biol; 1998; 443():229-37. PubMed ID: 9781363
[TBL] [Abstract][Full Text] [Related]
19. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
[TBL] [Abstract][Full Text] [Related]
20. Morphological response of mycoplasma to fleroxacin.
Werk R; Schneider L
Infection; 1989; 17(6):405-6. PubMed ID: 2515157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
